FDA Quietly Announces Office Of Pharmaceutical Quality Restructure

By Jessica Karins / November 13, 2023 at 5:08 PM

FDA’s Center for Drug Evaluation and Research (CDER) is reorganizing its Office of Pharmaceutical Quality (OPQ) as it works on a broader effort to stem drug shortages by encouraging manufacturers to go beyond regulatory requirements in addressing quality issues.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.